Clinical Trial Update: Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot study examining phosphodiesterase type 5 inhibition in aortic stenosis; trial terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Hypertrophy
• Left Ventricular Remodeling

Snippet

Sponsor: Washington University School of Medicine | Conditions: Aortic Stenosis, LV Remodeling, Hypertrophy | Phase 4 | Status: TERMINATED | Results posted: 2019-04-17